Letko, Brosseau & Associates Inc / CVS
Letko, Brosseau & Associates Inc’s Cvs Health Corp Position
Does Letko, Brosseau & Associates Inc own Cvs Health Corp (CVS)? Yes — 1.11M shares worth $80M (+1.29% of its 13F portfolio) as of Q1 2026, up from 1.11M shares the prior filed quarter.
Position Value
$80M
Q1 2026
Shares
1.11M
% of Portfolio
+1.29%
Quarters Held
22
currently held
Position History CVS
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 1.11M | $80M | +1.29% |
| Q4 2025 | 1.11M | $88M | +1.44% |
| Q3 2025 | 1.12M | $84M | +1.44% |
| Q2 2025 | 1.11M | $77M | +1.47% |
| Q1 2025 | 1.11M | $75M | +1.60% |
| Q4 2024 | 1.11M | $50M | +0.97% |
| Q3 2024 | 1.09M | $68M | +1.24% |
| Q2 2024 | 1.04M | $61M | +1.16% |
| Q1 2024 | 759.2K | $61M | +1.05% |
| Q4 2023 | 760.8K | $60M | +1.09% |
| Q3 2023 | 771.1K | $54M | +1.05% |
| Q2 2023 | 516.2K | $36M | +0.66% |
| Q1 2023 | 505.3K | $38M | +0.70% |
| Q4 2022 | 395.3K | $36,833 | +0.66% |
| Q3 2022 | 396.1K | $38M | +0.75% |
| Q2 2022 | 405.6K | $38M | +0.67% |
| Q1 2022 | 411.3K | $42M | +0.62% |
| Q4 2021 | 424.0K | $44M | +0.63% |
| Q3 2021 | 437.5K | $37M | +0.54% |
| Q2 2021 | 464.8K | $39M | +0.52% |
| Q1 2021 | 472.4K | $36M | +0.48% |
| Q4 2020 | 492.9K | $34M | +0.46% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Letko, Brosseau & Associates Inc’s full portfolio or all institutional holders of CVS.